BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15365135)

  • 21. Allodynia in migraine: clinical observation and role of prophylactic therapy.
    Misra UK; Kalita J; Bhoi SK
    Clin J Pain; 2013 Jul; 29(7):577-82. PubMed ID: 23328330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis.
    Schwedt TJ; Larson-Prior L; Coalson RS; Nolan T; Mar S; Ances BM; Benzinger T; Schlaggar BL
    Pain Med; 2014 Jan; 15(1):154-65. PubMed ID: 24165094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB; Munjal S; Buse DC; Bennett A; Fanning KM; Burstein R; Reed ML
    Headache; 2017 Jul; 57(7):1026-1040. PubMed ID: 28603893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can allodynic migraine patients be identified interictally using a questionnaire?
    Jakubowski M; Silberstein S; Ashkenazi A; Burstein R
    Neurology; 2005 Nov; 65(9):1419-22. PubMed ID: 16275830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinesiophobia Is Associated with Migraine.
    Benatto MT; Bevilaqua-Grossi D; Carvalho GF; Bragatto MM; Pinheiro CF; Straceri Lodovichi S; Dach F; Fernández-de-Las-Peñas C; Florencio LL
    Pain Med; 2019 Apr; 20(4):846-851. PubMed ID: 30462312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
    You DS; Haney R; Albu S; Meagher MW
    Headache; 2018 Jan; 58(1):62-77. PubMed ID: 29094347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allodynia in cluster headache.
    Wilbrink LA; Louter MA; Teernstra OPM; van Zwet EW; Huygen FJPM; Haan J; Ferrari MD; Terwindt GM
    Pain; 2017 Jun; 158(6):1113-1117. PubMed ID: 28267062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
    Dallel R; Descheemaeker A; Luccarini P
    Cephalalgia; 2018 Apr; 38(4):776-785. PubMed ID: 28565942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allodynia in migraine: frequent random association or unavoidable consequence?
    Lovati C; D'Amico D; Bertora P
    Expert Rev Neurother; 2009 Mar; 9(3):395-408. PubMed ID: 19271948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease.
    Benatto MT; Florencio LL; Carvalho GF; Dach F; Bigal ME; Chaves TC; Bevilaqua-Grossi D
    Arq Neuropsiquiatr; 2017 Mar; 75(3):153-159. PubMed ID: 28355322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
    Dodick DW; Reed ML; Fanning KM; Munjal S; Alam A; Buse DC; Schwedt TJ; Lipton RB
    Cephalalgia; 2019 Jun; 39(7):873-882. PubMed ID: 30732460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous Allodynia and Its Risk Factors in Korean Patients with Migraine: A Survey of Two Tertiary Care Hospitals.
    Kim SY; Park SP
    J Oral Facial Pain Headache; 2016 Fall; 30(4):323-329. PubMed ID: 27792800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA.
    Ozarslan M; Matur Z; Tuzun E; Oge AE
    Clin Neurol Neurosurg; 2022 Sep; 220():107357. PubMed ID: 35792471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Botulinum Toxin A on Allodynia in Chronic Migraine: An Observational Open-Label Two-Year Study.
    de Tommaso M; Brighina F; Delussi M
    Eur Neurol; 2019; 81(1-2):37-46. PubMed ID: 31013496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric comorbidities in allodynic migraineurs.
    Kao CH; Wang SJ; Tsai CF; Chen SP; Wang YF; Fuh JL
    Cephalalgia; 2014 Mar; 34(3):211-8. PubMed ID: 24048892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of ictal cutaneous allodynia on the response to occipital transcutaneous electrical stimulation in chronic migraine and chronic tension-type headache: a randomized, sham-controlled study.
    Bono F; Salvino D; Mazza MR; Curcio M; Trimboli M; Vescio B; Quattrone A
    Cephalalgia; 2015 Apr; 35(5):389-98. PubMed ID: 25078717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous allodynia in the migraine population.
    Lipton RB; Bigal ME; Ashina S; Burstein R; Silberstein S; Reed ML; Serrano D; Stewart WF;
    Ann Neurol; 2008 Feb; 63(2):148-58. PubMed ID: 18059010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile migraine and allodynia: results of a retrospective study.
    Raieli V; Trapolino D; Giordano G; Spitaleri C; Consolo F; Santangelo G; Buffa D; Vanadia F; D'Amelio M
    Headache; 2015 Mar; 55(3):413-8. PubMed ID: 25760465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine.
    LoPinto C; Young WB; Ashkenazi A
    Cephalalgia; 2006 Jul; 26(7):852-6. PubMed ID: 16776701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.